- Home
- ARAY vs NHS Comparison
ARAY vs NHS Comparison
Compare ARAY & NHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARAY
- NHS
- Stock Information
- Founded
- ARAY 1990
- NHS 2003
- Country
- ARAY United States
- NHS United States
- Employees
- ARAY N/A
- NHS N/A
- Industry
- ARAY Medical/Dental Instruments
- NHS Trusts Except Educational Religious and Charitable
- Sector
- ARAY Health Care
- NHS Finance
- Exchange
- ARAY Nasdaq
- NHS Nasdaq
- Market Cap
- ARAY 229.3M
- NHS 221.6M
- IPO Year
- ARAY 2007
- NHS N/A
- Fundamental
- Price
- ARAY $1.59
- NHS $7.58
- Analyst Decision
- ARAY
- NHS
- Analyst Count
- ARAY 0
- NHS 0
- Target Price
- ARAY N/A
- NHS N/A
- AVG Volume (30 Days)
- ARAY 673.3K
- NHS 111.8K
- Earning Date
- ARAY 04-30-2025
- NHS 01-01-0001
- Dividend Yield
- ARAY N/A
- NHS 13.44%
- EPS Growth
- ARAY N/A
- NHS N/A
- EPS
- ARAY 0.01
- NHS N/A
- Revenue
- ARAY $465,251,000.00
- NHS N/A
- Revenue This Year
- ARAY $3.87
- NHS N/A
- Revenue Next Year
- ARAY $0.09
- NHS N/A
- P/E Ratio
- ARAY $237.85
- NHS N/A
- Revenue Growth
- ARAY 8.06
- NHS N/A
- 52 Week Low
- ARAY $1.28
- NHS $6.95
- 52 Week High
- ARAY $2.95
- NHS $9.17
- Technical
- Relative Strength Index (RSI)
- ARAY 51.00
- NHS 55.17
- Support Level
- ARAY $1.49
- NHS $7.38
- Resistance Level
- ARAY $1.77
- NHS $7.61
- Average True Range (ATR)
- ARAY 0.07
- NHS 0.09
- MACD
- ARAY 0.00
- NHS 0.01
- Stochastic Oscillator
- ARAY 35.71
- NHS 70.41
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
About NHS Neuberger Berman High Yield Strategies Fund
Neuberger Berman High Yield Strategies Fund is closed-end management investment company. It seeks to achieve its investment objective by investing, under normal market conditions, a majority of its total assets in high yield debt securities of U.S. and foreign issuers.